IN-VITRO CHARACTERIZATION OF POLYMERIC MEMBRANE USED FOR CONTROLLED-RELEASE APPLICATION

被引:11
|
作者
PHUAPRADIT, W
SHAH, NH
RAILKAR, A
WILLIAMS, L
INFELD, MH
机构
[1] Pharmaceutical R and D, Hoffmann-La Roche Inc., Nutley, NJ, 07110
关键词
D O I
10.3109/03639049509026659
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The application of a polymer film coat is a common practice in the preparation of controlled release dosage forms. In vitro characterization of the polymeric membrane is essential for optimization of the membrane formulation. Polymers selected in this study were cellulose acetate (CA), ethylcellulose (EC) and copolymers of acrylic and methacrylic esters (Eudragit RL100). Plasticizers used in this study were dibutyl sebacate (DBS), triethyl citrate (TEC) and triacetin. Polymer dispersions containing different plasticizers were cast into membranes on a teflon-coated plate. The resulting membranes were evaluated for permeability and mechanical properties. Membrane permeability was determined by quantifying the transport of a model drug, theophylline, across a circular polymeric membrane mounted in a thermostatted, two-compartment horizontal diffusion cell. Mechanical properties of the membranes, such as tensile strength, percent elongation and modulus of elasticity, were determined using an Instron 4301. The results of this study indicate that the CA and EC membranes were found to be effective in preventing the diffusion of theophylline. The addition of Eudragit RL100 to the CA or EC membranes increased the permeability but decreased the mechanical strength of the resulting membrane(s). A significant increase in permeability was observed at a CA:Eudragit RL100 ratio of 60:40. This could be explained by a change in the mechanism of drug transport, principally from partitioning into the membrane to diffusing through the liquid-filled pores of the resulting membrane(s). The results of the mechanical deformation studies indicate that triacetin has a greater potential for partitioning into the CA polymer than does TEC or DBS. DBS has a greater potential for partitioning into the EC polymer than does TEC or triacetin. The addition of Eudragit RL100 to the CA membrane(s) caused a significant decrease in the tensile strength, percent elongation and modulus of elasticity, thus resulting in weaker and softer membranes. The results indicate that the test methods employed were sufficiently sensitive to quantify the test parameters for the changes in The application of a polymer film coat is a common practice in the preparation of controlled release dosage forms. Since diffusion through a membrane is a simple approach to obtain a predictable release rate, membrane-controlled devices have been widely used. A device for constant release consists of a central reservoir of a drug enclosed by a polymeric membrane that allows the drug to diffuse from the reservoir at predetermined rate. In vitro characterization of the polymeric membrane is essential for optimization of the membrane formulation. In this study, the effects of types of polymers and plasticizers on permeability and mechanical properties of the membranes were evaluated. Cellulosic polymers and copolymers of acrylic and methacrylic esters (Eudragit RL100), which have been widely used as controlled release coating polymers (1-3), were selected for evaluation. Dibutyl sebacate, triethyl citrate and triacetin were used as plasticizers in this study.
引用
收藏
页码:955 / 963
页数:9
相关论文
共 50 条
  • [21] USE OF IN-VITRO RELEASE TESTS FOR THE PREDICTION OF THE IN-VIVO BEHAVIOR AND THE DEVELOPMENT OF FLUCYTOSINE CONTROLLED-RELEASE CAPSULES
    BONNY, JD
    KYOWA, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (05) : 619 - 623
  • [22] IN-VITRO AND IN-VIVO EVALUATION OF A ONCE-DAILY CONTROLLED-RELEASE PSEUDOEPHEDRINE PRODUCT
    HWANG, SS
    GORSLINE, J
    LOUIE, J
    GUINTA, D
    HAMEL, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03): : 259 - 267
  • [23] IN-VITRO CONTROLLED-RELEASE OF ISONIAZID FROM POLY(LACTIDE-CO-GLYCOLIDE) MATRICES
    HSU, YY
    GRESSER, JD
    TRANTOLO, DJ
    LYONS, CM
    GANGADHARAM, PRJ
    WISE, DL
    JOURNAL OF CONTROLLED RELEASE, 1994, 31 (03) : 223 - 228
  • [24] IN-VIVO VERSUS IN-VITRO DEGRADATION OF CONTROLLED-RELEASE POLYMERS FOR INTRACRANIAL SURGICAL THERAPY
    WU, MP
    TAMADA, JA
    BREM, H
    LANGER, R
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (03): : 387 - 395
  • [25] A FLOATING CONTROLLED-RELEASE DRUG-DELIVERY SYSTEM - IN-VITRO IN-VIVO EVALUATION
    DESAI, S
    BOLTON, S
    PHARMACEUTICAL RESEARCH, 1993, 10 (09) : 1321 - 1325
  • [26] CONTROLLED-RELEASE OF A CONTRACEPTIVE STEROID FROM BIODEGRADABLE AND INJECTABLE GEL FORMULATIONS - IN-VITRO EVALUATION
    GAO, ZH
    SHUKLA, AJ
    JOHNSON, JR
    CROWLEY, WR
    PHARMACEUTICAL RESEARCH, 1995, 12 (06) : 857 - 863
  • [27] PHARMACOKINETIC CHARACTERIZATION OF CONTROLLED-RELEASE FORMULATIONS
    STEINIJANS, VW
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) : 173 - 181
  • [28] Preparation and in-vitro evaluation of different controlled release polymeric matrices containing Ketoprofen
    Khan, Jiyauddin
    Yuen, Kah Hay
    Hong, Ng Bee
    Chitneni, Mallikarjun
    Elhassan, Gamal Osman
    Al-Dhalli, Samer
    HEALTHMED, 2010, 4 (02): : 386 - 392
  • [29] CONTROLLED-RELEASE OF INDOMETHACIN BY CHITOSAN-POLYELECTROLYTE COMPLEX - OPTIMIZATION AND IN-VIVO IN-VITRO EVALUATION
    SHIRAISHI, S
    IMAI, T
    OTAGIRI, M
    JOURNAL OF CONTROLLED RELEASE, 1993, 25 (03) : 217 - 225
  • [30] EXTENDED IMMUNOSUPPRESSION WITH CYCLOPHOSPHAMIDE USING CONTROLLED-RELEASE POLYMERIC IMPLANTS
    ORMROD, DJ
    CAWLEY, S
    MILLER, TE
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (04): : 443 - 448